No CrossRef data available.
Article contents
Substantial Amendment of the EU Regulatory Framework on Medical Devices and International Trade Implications
Published online by Cambridge University Press: 20 January 2017
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Reports
- Information
- Copyright
- Copyright © Cambridge University Press 2013
References
1 COM(2012) 542.
2 COM(2012) 541.
3 There is reportedly an increasing trend in EU medicines agencies of “medical device” applications for food supplement products which have been rejected under the strict EU health claims framework, set out in Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods, OJ 2006 L 404/9). See: Shane Starling, “EU medical devices route tempts article 13 health claim losers”, 3 January 2013, available on the Internet at: <http://www.nutraingredients.com/Regulation/EU-medical-devices-route-temptsarticle-13-health-claim-losers> (last accessed on 3 January 2013).
4 OJ 1990 L 189/17.
5 OJ 1993 L 169/1.
6 OJ 1998 L 331/1.
7 COM(2012) 540 final.
8 OJ 2011 C 202/7.
9 European Parliament Document P7_TA(2012)0262.
10 See on the Internet at: <http://www.ghtf.org> (last accessed on 3 January 2013).
11 See on the Internet at: <http://www.imdrf.org> (last accessed on 3 January 2013).
12 WTO Doc. G/TBT/N/EU/71 and WTO Doc. G/TBT/N/EU/72.
13 WTO Doc. G/TBT/N/BRA/440.
14 OJ 2002 L 31/1.
15 OJ 2003 L 268/24.
16 OJ 2004 L 10/5.